Growth Metrics

National Research (NRC) Current Deferred Revenue (2016 - 2025)

National Research's Current Deferred Revenue history spans 16 years, with the latest figure at $16.2 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 2.63% year-over-year to $16.2 million; the TTM value through Dec 2025 reached $16.2 million, up 2.63%, while the annual FY2025 figure was $16.2 million, 2.63% up from the prior year.
  • Current Deferred Revenue for Q4 2025 was $16.2 million at National Research, down from $17.8 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $17.8 million in Q3 2025 and bottomed at $14.5 million in Q2 2024.
  • The 5-year median for Current Deferred Revenue is $16.0 million (2023), against an average of $16.2 million.
  • The largest annual shift saw Current Deferred Revenue rose 10.45% in 2021 before it decreased 11.71% in 2022.
  • A 5-year view of Current Deferred Revenue shows it stood at $17.2 million in 2021, then decreased by 11.71% to $15.2 million in 2022, then decreased by 2.4% to $14.8 million in 2023, then increased by 6.42% to $15.8 million in 2024, then grew by 2.63% to $16.2 million in 2025.
  • Per Business Quant, the three most recent readings for NRC's Current Deferred Revenue are $16.2 million (Q4 2025), $17.8 million (Q3 2025), and $15.6 million (Q2 2025).